Enhanced Th1 and Th17 responses in peripheral blood in active non-segmental vitiligo
- PMID: 27687555
- DOI: 10.1007/s00403-016-1690-3
Enhanced Th1 and Th17 responses in peripheral blood in active non-segmental vitiligo
Abstract
Accumulating studies have indicated that vitiligo, especially non-segmental vitiligo (NSV), is one kind of autoimmune diseases and CD4+ T cells play important roles in the pathogenesis. However, there have been very limited data on the detailed changes of each of the CD4+ T cell subsets in periphery in active NSV. To clarify this issue, we collected the peripheral blood mononuclear cells (PBMCs) from 30 patients with active NSV and 30 age- and sex-matched healthy controls. The percentages of circulating Th1, Th2, Th17 and Tregs were evaluated using flow cytometry and the expressions of their specific transcription factors T-bet, GATA3, RORγt and FOXP3 at mRNA level and protein levels were qualified by qPCR and flow cytometry, respectively. Meanwhile, the expression levels of IFN-γ, IL-4, TGF-β, and IL-17A in serum were measured. We found that in patients with NSV, the percentages and absolute numbers of circulating Th1 and Th17 were both significantly higher than those of healthy controls, while the percentages of Th2 and Tregs and absolute numbers showed no significant difference compared to healthy controls. Moreover, the ratios of Th1/Tregs and Th17/Tregs in circulation were both statistically elevated in active NSV. Similar results were got in qualification of their corresponding transcription factors at mRNA level and protein levels. Compared with healthy controls, the expression level of IL-17A was significantly increased in serum of patients with NSV, while the productions of IFN-γ, IL-4, TGF-β had no significant change. These data suggested that in circulating CD4+ T cell subsets, Th1 and Th17 played the major role in cellular immunity in the progression of vitiligo. The immune lever in circulation was inclined to effector CD4+ T cells not suppressor CD4+ T cells that may result in the loss of self-tolerance to melanocytes.
Keywords: Autoimmunity; CD4+ T cells; Non-segmental vitiligo.
Similar articles
-
Increased circulating Th17 cells and elevated serum levels of TGF-beta and IL-21 are correlated with human non-segmental vitiligo development.Pigment Cell Melanoma Res. 2015 May;28(3):324-9. doi: 10.1111/pcmr.12355. Epub 2015 Feb 13. Pigment Cell Melanoma Res. 2015. PMID: 25604047
-
Increased interleukin-27 promotes Th1 differentiation in patients with chronic immune thrombocytopenia.Scand J Immunol. 2014 Oct;80(4):276-82. doi: 10.1111/sji.12197. Scand J Immunol. 2014. PMID: 24909905
-
Th1/Th2/Th17/Treg cytokine imbalance in systemic lupus erythematosus (SLE) patients: Correlation with disease activity.Cytokine. 2015 Apr;72(2):146-53. doi: 10.1016/j.cyto.2014.12.027. Epub 2015 Jan 31. Cytokine. 2015. PMID: 25647269
-
A cellular and molecular view of T helper 17 cell plasticity in autoimmunity.J Autoimmun. 2018 Feb;87:1-15. doi: 10.1016/j.jaut.2017.12.007. Epub 2017 Dec 22. J Autoimmun. 2018. PMID: 29275836 Review.
-
Role of Th1 and Th17 cells in organ-specific autoimmunity.J Autoimmun. 2008 Nov;31(3):252-6. doi: 10.1016/j.jaut.2008.04.017. Epub 2008 May 27. J Autoimmun. 2008. PMID: 18502610 Free PMC article. Review.
Cited by
-
Multiple gene-drug prediction tool reveals Rosiglitazone based treatment pathway for non-segmental vitiligo.Inflammation. 2024 Apr;47(2):678-695. doi: 10.1007/s10753-023-01937-9. Epub 2023 Dec 30. Inflammation. 2024. PMID: 38159176 Free PMC article.
-
The Role of TRM Cells in the Pathogenesis of Vitiligo-A Review of the Current State-Of-The-Art.Int J Mol Sci. 2020 May 18;21(10):3552. doi: 10.3390/ijms21103552. Int J Mol Sci. 2020. PMID: 32443482 Free PMC article. Review.
-
Increased Circulatory Interleukin-17A Levels in Patients with Progressive and Leukotrichial Vitiligo.Dermatol Res Pract. 2021 Apr 21;2021:5524566. doi: 10.1155/2021/5524566. eCollection 2021. Dermatol Res Pract. 2021. PMID: 33968147 Free PMC article.
-
Pregnancy outcomes in women with vitiligo: A Taiwanese nationwide cohort study.PLoS One. 2021 Mar 22;16(3):e0248651. doi: 10.1371/journal.pone.0248651. eCollection 2021. PLoS One. 2021. PMID: 33750961 Free PMC article.
-
Therapeutic implications of baricitinib in mouse model of vitiligo.Arch Dermatol Res. 2025 Feb 7;317(1):353. doi: 10.1007/s00403-025-03879-8. Arch Dermatol Res. 2025. PMID: 39918618
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials